Dr Reddys Laboratories (RDY) Shares Outstanding (Diluted Average) (2012 - 2023)

Dr Reddys Laboratories' Shares Outstanding (Diluted Average) history runs 12 years deep, the most recent figure standing at $1.1 million for Q2 2023.

• In Q2 2023, Shares Outstanding (Diluted Average) rose 24.57% year-over-year to $1.1 million; the TTM figure through Jun 2023 stood at $1.1 million (up 24.57% YoY), while the FY2023 annual figure was $1.0 million, up 9.51% from the prior year.
• Shares Outstanding (Diluted Average) was $1.1 million for Q2 2023 at Dr Reddys Laboratories, up from $1.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $1.1 million in Q2 2023 to a low of $15977.9 in Q3 2020.
• Historically, Shares Outstanding (Diluted Average) has averaged $635734.2 across 5 years, with a median of $602701.7 in 2020.
• The sharpest annual moves came in 2020 and 2021: Shares Outstanding (Diluted Average) tumbled 96.14% in 2020, then surged 3488.2% in 2021.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $414386.5 in 2019, then declined by 28.77% to $295161.3 in 2020, then slumped by 76.22% to $70203.1 in 2021, then soared by 899.68% to $701807.4 in 2022, then surged by 53.97% to $1.1 million in 2023.
• The last three Shares Outstanding (Diluted Average) figures came in at $1.1 million (Q2 2023), $1.0 million (Q1 2023), and $701807.4 (Q4 2022), per Business Quant data.